View in EDS HTML Full Text PDF Full Text

Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.

Saved in:
Bibliographic Details
Title: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
Authors: Yang, Shuo1 (AUTHOR), Hou, Yibing2 (AUTHOR), Wang, Xiaohui3 (AUTHOR), Kang, Shuo4 (AUTHOR) shuok628@hebmu.edu.cn, Pan, Zhenhua3 (AUTHOR) panzhenhua@hebmu.edu.cn
Source: PLoS ONE. 6/11/2026, Vol. 21 Issue 6, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194491510
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Yang%2C+Shuo%22">Yang, Shuo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hou%2C+Yibing%22">Hou, Yibing</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Xiaohui%22">Wang, Xiaohui</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kang%2C+Shuo%22">Kang, Shuo</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> shuok628@hebmu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Pan%2C+Zhenhua%22">Pan, Zhenhua</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> panzhenhua@hebmu.edu.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 6/11/2026, Vol. 21 Issue 6, p1-9. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194491510
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0351029
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1
    Titles:
      – TitleFull: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang, Shuo
      – PersonEntity:
          Name:
            NameFull: Hou, Yibing
      – PersonEntity:
          Name:
            NameFull: Wang, Xiaohui
      – PersonEntity:
          Name:
            NameFull: Kang, Shuo
      – PersonEntity:
          Name:
            NameFull: Pan, Zhenhua
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 06
              Text: 6/11/2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1